Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    5.00 (1.10%)
Bid:
455.50
Ask:
460.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Option grants /PDMR Shareholding

26 Mar 2021 16:11

RNS Number : 7007T
Frontier Developments PLC
26 March 2021
Β 

Frontier Developments plc

Director/PDMR Shareholding

Frontier Developments plc (AIM: FDEV, "Frontier", the "Company") announces that on 25 March 2021, in aggregate options over 33,924 Ordinary Shares of 0.5p each in the Company ("Ordinary Shares") have been awarded under the existing all-staff Sharesave equity plan (the "Plan"), which Directors are also entitled to participate in. 1,824 options with an exercise price of 1,972 pence per Ordinary Share were granted to two of the Executive Directors (the "Options"). The Options are due to vest on 1 May 2024, after which they must be exercised within six months.

Following these grants, the number of Ordinary Shares held under option by each of the Executive Directors is as follows:

Name of Director

Position

Number of Options granted on 25 March 2021

Total number of share options held under all schemes

Jonathan Watts

Chief Creative Officer

912

146,234

Alex Bevis

Chief Financial Officer and Company Secretary

912

168,888

Β 

Enquiries:

Frontier DevelopmentsΒ Β Β +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFOΒ 

Β 

Liberum - Nomad and Joint BrokerΒ Β Β +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

Β 

Jefferies - Joint BrokerΒ Β Β +44 (0)20 7029 8000

Max Jones / William Brown

Β 

Tulchan CommunicationsΒ Β Β +44 (0)20 7353 4200

Matt Low / William Booth / Tom Blundell / David Allchurch

Β 

Β About Frontier Developments plc

Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.Β Β Β Β 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jonathan Watts

2.Β Β Β Β 

Reason for the notification

a)

Position/status: Chief Creative Officer

b)

Initial notification/Amendment: Initial Notification

3.Β Β Β Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.Β Β Β Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transactions: Grant of 912 options over ordinary shares of 0.5 pence each with an exercise price of 1,972 pence per share. The Options are due to vest on 1 May 2024, after which they must be exercised within 6 months.

c)

Β 

Β 

Price(s) and volume(s):

Price(s)

Volume(s)

1,972p

912

d)

Aggregated information:

N/A - Single transaction

e)

Date of the transaction: 25 March 2021

f)

Place of the transaction: Outside trading venue

Β 

Β 

1.Β Β Β Β 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Alexander Bevis

2.Β Β Β Β 

Reason for the notification

a)

Position/status: CFO and Company Secretary

b)

Initial notification/Amendment: Initial Notification

3.Β Β Β Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.Β Β Β Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transactions: Grant of 912 options over ordinary shares of 0.5 pence each with an exercise price of 1,972 pence per share. The Options are due to vest on 1 May 2024, after which they must be exercised within 6 months.

c)

Β 

Β 

Price(s) and volume(s):

Price(s)

Volume(s)

1,972p

912

d)

Aggregated information:

N/A - Single transaction

e)

Date of the transaction: 25 March 2021

f)

Place of the transaction: Outside trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPPUGGWUPGGQQ
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.